SFA Therapeutics is a clinical stage start-up biotech company with a platform technology based on Nobel Prize winning research. This patented and proprietary platform is based on the immuno-modulation of inflammatory factors through innate T-Regulatory (Treg) cell differentiation. The technology is licensed from and supported by research at Temple University in Philadelphia. The result is a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.
| Website | http://www.sfatherapeutics.com |
| Employees | 9 (3 on RocketReach) |
| Founded | 2017 |
| Address | 610 Old York Rd Suite 400, Jenkintown, Pennsylvania 19046, US |
| Phone | +1 267-584-1080 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Drug Discovery, Science and Engineering |
| Keywords | Gut Microbiome, Human Microbiome, Biotechnology, Drug Development, Microbiome Therapeutics, Therapeutics, Clinical Stage, Biopharma, Immunomodulation, Pharmaceutical, Immunotherapy, Compounds, Clinical Trials, Inflammatory Diseases, Proprietary Technology, Precision Medicine, Inflammatory Bowel Disease, Crohn's Disease, Ulcerative Colitis |
| Competitors | Pfizer, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences, Receptos, a wholly-owned subsidiary of Celgene, Sorrento Therapeutics, Inc., Lilly India +36 more (view full list) |
Looking for a particular SFA Therapeutics employee's phone or email?
SFA Therapeutics Questions
Ira Spector is the CEO of SFA Therapeutics.
3 people are employed at SFA Therapeutics.
SFA Therapeutics is based in Jenkintown, Pennsylvania.
Top SFA Therapeutics Employees
-
Ira Spector
CEO at SFA Therapeutics
Philadelphia, PA, US45+ -
25+
-
13
Related Companies
